Elaboration de Fiches Patients pour les Patients Sous-Anticancéreux

Abstract

According to data from the National Cancer Registry of the National Institute of Public Health (INSP), Algeria registers nearly 50,000 cases of cancer of all types combined annually. According to the president of the Algerian Society of Medical Oncology (SAOM), this number will increase in the next five years at the same rate as that of developed countries. The care of people with cancer is becoming a real public health issue, due to the drug iatrogenic effects that cancer treatment can cause. The main objective of this work was to develop advice sheets for patients on cancer drugs in order to inform them about their treatments and help them to adapt to them. In addition, recall the role of the pharmacist in the care pathway for these patients. For this, questionnaires aimed at estimating the knowledge of patients about their treatments and assessing the adverse effects endured have been developed. The study was carried out at the level of the anti-cancer center (CAC) of the wilaya of Sétif, over the extended period from March 17 to June 16, 2022, with 50 patients with breast cancer and colorectal cancer. The analysis of the results showed that the majority of patients 70% do not have enough information about their treatments, 72% have already had adverse effects and more than 40% have never been informed about what to do in the face of these effects, which shows a lack of patient information which can be multi-factorial. Other parameters were studied, in particular the risk of drug and food interactions, as well as the use of phytotherapy. The results reported by our study, although not exhaustive, confirm the importance of a rigorous and organized follow-up of the patient under anti-cancer drugs, also, the implication of any professional having the necessary skills, including the pharmacist who is an actor major and a main link between the patient, his treatment, is the other health professionals.